Cynosure and Hahn & Company, following its recent acquisition of Lutronic, has announced a definitive merger agreement between Cynosure and Lutronic, both renowned global providers of energy-based medical aesthetic treatment systems and related technologies. This highly anticipated merger is set to be finalized in the first quarter of 2024, pending customary closing conditions. While the specific terms of the transaction have not been disclosed, the merger is a significant event in the medical aesthetics industry.

Implications of the Merger: A New Era in Medical Aesthetics

The strategic union of Cynosure and Lutronic marks the formation of a global leader in the medical aesthetics sector. The combined entity will boast a diversified and innovative product portfolio, with a commercial presence spanning over 130 countries. This merger will offer an expanded suite of products and consumables, deeper clinical training and services, and enhanced research and development capabilities. Additionally, the combined company will benefit from an expanded geographic footprint, allowing it to serve a broader customer base and ensuring a reinforced supply chain for uninterrupted product and service delivery.

Nadav Tomer, CEO of Cynosure, expressed enthusiasm for the merger, citing the combined resources, product portfolio, and expertise that will benefit customers, partners, and employees. Haelyung Hwang, Founder and CEO of Lutronic, also emphasized the transformative nature of this partnership, aligning with Lutronic’s mission to drive innovation and provide superior products and customer service in the aesthetics sector.

Advisors and Legal Counsel in the Merger Process

Jefferies LLC served as the exclusive financial advisor to Cynosure, with Weil, Gotshal & Manges LLP and Debevoise & Plimpton LLP providing legal advice. On the other hand, PJT Partners LP acted as the exclusive financial advisor for Lutronic, with legal counsel from Cleary Gottlieb Steen & Hamilton LLP and Kim & Chang.

Expert Opinion and Industry Perspective

The merger between Cynosure and Lutronic is a strategic move that reflects the evolving dynamics of the medical aesthetics industry. By combining their strengths, the new entity is poised to become a powerhouse in innovation and global market reach. This merger not only signifies the growth potential within the medical aesthetics field but also highlights the increasing demand for advanced, technology-driven aesthetic solutions globally.

  Cynosure and Hahn & Company, Haelyung Hwang, Lutronic, Nadav Tomer